Skip to main content
Steven Stein, MD, Oncology, Philadelphia, PA

Steven Harry Stein MD


Physician

Join to View Full Profile
  • 51 N 39th StSuite 103Philadelphia, PA 19104

  • Phone+1 215-662-8947

  • Fax+1 215-615-0500

Are you Dr. Stein?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Steven Stein, MD is an oncologist in Philadelphia, Pennsylvania. He is currently licensed to practice medicine in Pennsylvania.

Education & Training

  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 1998 - 2001
  • Albert Einstein Healthcare Network
    Albert Einstein Healthcare NetworkResidency, Internal Medicine, 1994 - 1997
  • University of the Witwatersrand
    University of the WitwatersrandClass of 1990

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 1995 - 2026
  • PA State Medical License
    PA State Medical License 1997 - 2026
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Hematology
    American Board of Internal Medicine Hematology
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Press Mentions

  • Incyte Late-Breaking Tafasitamab (Monjuvi®) Data at ASH 2024 Demonstrate Significantly Improved Progression-Free Survival in Patients with Relapsed or Refractory Follicular Lymphoma
    Incyte Late-Breaking Tafasitamab (Monjuvi®) Data at ASH 2024 Demonstrate Significantly Improved Progression-Free Survival in Patients with Relapsed or Refractory Follicular LymphomaDecember 10th, 2024
  • Data from Incyte’s Oncology Portfolio Accepted for Presentation at the 2021 ASCO Annual Meeting
    Data from Incyte’s Oncology Portfolio Accepted for Presentation at the 2021 ASCO Annual MeetingMay 19th, 2021
  • Incyte Announces Data from Multiple Programs Within Its Oncology Portfolio Accepted for Presentation at the AACR Annual Meeting 2021
    Incyte Announces Data from Multiple Programs Within Its Oncology Portfolio Accepted for Presentation at the AACR Annual Meeting 2021March 11th, 2021
  • Join now to see all